<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503241</url>
  </required_header>
  <id_info>
    <org_study_id>PRICESEOBESE</org_study_id>
    <nct_id>NCT02503241</nct_id>
  </id_info>
  <brief_title>Open Lung Strategy in Critically Ill Morbid Obese Patients</brief_title>
  <official_title>Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this interventional crossover study in morbidly obese intubated and mechanically
      ventilated patients is to describe the respiratory mechanics and the heart-lung interaction
      at titrated positive end-expiratory pressure levels following a recruitment maneuver with
      transthoracic echocardiography and electric impedance tomography imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obese patients under mechanical ventilation are more likely to develop atelectasis as a
      consequence of the increased abdominal weight. Atelectasis is the primary responsible for
      respiratory insufficiency and impossibility to wean obese patients from respiratory support.

      In a previous study we demonstrated the efficacy of the application of titrated PEEP levels
      following a recruitment maneuver in obese patients, i.e. improvement in respiratory mechanics
      and gas exchanges without negative hemodynamic effects.

      The application of lung and heat imaging will allow us to quantitatively describe:

        -  Increase in aerated lung tissue (reduction of atelectasis)

        -  Reduction of over-inflation of the ventilated regions

        -  Recoupling of ventilation and perfusion

        -  Improvement in right heart function by reduction of right heart afterload
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Physiologic crossover study. There is no randomization. All participants will receive the same interventions in the same order.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory System Elastance</measure>
    <time_frame>During study time points :baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Difference in Respiratory System Elastance measured in cmH2O/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung mechanics - Compliance</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Difference in respiratory system, lung and chest wall compliance measured in mL/cmH2O</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung mechanics - Airway resistances</measure>
    <time_frame>During study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Difference in resistances of the airways measured as cmH2O/L/sec (Raw)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>28 days after the performance of the study protocol</time_frame>
    <description>Incidence of death among the study population</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Intra-abdominal pressure</measure>
    <time_frame>Study time point: baseline</time_frame>
    <description>Changes in bladder pressure measured in mmHg.</description>
  </other_outcome>
  <other_outcome>
    <measure>Electrical Impedance Tomography measurement: collapsed and overdistension</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Percentage of lung tissue collapsed and over distended at different PEEP levels by analyzing pixel compliance ( variation in impedance divided by applied pressure during a respiratory cycle).</description>
  </other_outcome>
  <other_outcome>
    <measure>Electrical Impedance Tomography measurement: distribution of ventilation</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Difference in end-expiratory lung impedance as percentage estimating the distribution of ventilation among 4 horizontal regions of interest ( from non-dependent to dependent lung regions).</description>
  </other_outcome>
  <other_outcome>
    <measure>Electrical Impedance Tomography measurement: lung perfusion</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Differences in distribution in lung perfusion measured as regional percentage of the total cardiac output.</description>
  </other_outcome>
  <other_outcome>
    <measure>Central venous pressure</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Changes in central venous pressure (CVP, mmHg)</description>
  </other_outcome>
  <other_outcome>
    <measure>Gas Exchange - Oxygenation</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Difference in oxygenation measured in mmHg of PaO2/FiO2</description>
  </other_outcome>
  <other_outcome>
    <measure>Gas Exchange - Arterial carbon dioxide</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Difference in arterial carbon dioxide measured in mmHg (PaCO2)</description>
  </other_outcome>
  <other_outcome>
    <measure>Lung volumes - respiratory dead space</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental.</time_frame>
    <description>Difference in dead space fraction measured as the ratio of death volume over the total tidal volume (Vd/Vt)</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart rate</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Changes in heart rate (HR, bpm)</description>
  </other_outcome>
  <other_outcome>
    <measure>Blood pressure</measure>
    <time_frame>A) 48 and 24h before study procedures B)Study time points: baseline, PEEP incremental, PEEP decremental C)Follow up: 1, 2 , 24, 48 and 72 hours after study procedures.</time_frame>
    <description>Changes in invasive arterial blood pressures (BP, mmHg)</description>
  </other_outcome>
  <other_outcome>
    <measure>Right heart function -Tricuspid Annular Plane Systolic Excursion (TAPSE)</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Differences in TAPSE measured through two-dimensional transthoracic echocardiography (apical four-chamber view).</description>
  </other_outcome>
  <other_outcome>
    <measure>Right heart function - S'</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures</time_frame>
    <description>Differences in the systolic excursion of the tricuspid annulus measured by tissue doppler imaging.</description>
  </other_outcome>
  <other_outcome>
    <measure>Right heart function - Tei index</measure>
    <time_frame>Study time points: baseline, PEEP incremental, PEEP decremental</time_frame>
    <description>Differences in global right ventricular function obtained from right ventricle tissue doppler imaging.</description>
  </other_outcome>
  <other_outcome>
    <measure>Vasopressor requirement</measure>
    <time_frame>48, 24h before AND 24, 48 and 72h after study procedures.</time_frame>
    <description>Norepinephrine (mcg/kg/min), epinephrine (mcg/kg/min) , phenylephrine ( mcg/kg/min) and vasopressin (U / min)</description>
  </other_outcome>
  <other_outcome>
    <measure>Creatinine</measure>
    <time_frame>48, 24h before AND 24, 48 and 72h after study procedures.</time_frame>
    <description>Serum level of creatinine</description>
  </other_outcome>
  <other_outcome>
    <measure>Urinary output</measure>
    <time_frame>48, 24h before AND 24, 48 and 72h after study procedures.</time_frame>
    <description>Changes in urinary output (mL)</description>
  </other_outcome>
  <other_outcome>
    <measure>Fluid balance</measure>
    <time_frame>48, 24h before AND 24, 48 and 72h after study procedures.</time_frame>
    <description>Changes in fluid balance (mL)</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of tracheostomy</measure>
    <time_frame>28 days after the performance of the study protocol</time_frame>
    <description>Necessity of tracheostomy for prolonged ventilatory support among the study population</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>28 days after the performance of the study protocol</time_frame>
    <description>Number of days on mechanical ventilation</description>
  </other_outcome>
  <other_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>28 days after the performance of the study protocol</time_frame>
    <description>Numbers of days spent in the intensive care</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>28 days after the performance of the study protocol</time_frame>
    <description>Numbers of days spent in the hospital</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Obesity</condition>
  <condition>Respiratory Insufficiency</condition>
  <condition>Right-Sided Heart Failure</condition>
  <condition>Pulmonary Atelectasis</condition>
  <condition>Respiratory Mechanics</condition>
  <arm_group>
    <arm_group_label>PEEP_Titration_INCREMENTAL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators will compare 3 levels of PEEP (BASELINE versus PEEP INCREMENTAL versus PEEP DECREMENTAL). Baseline PEEP is based in the standard of care PEEP used in the participant units. PEEP incremental value is based in transpulmonary pressure.
Intervention : PEEP INCREMENTAL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEEP_Titration_DECREMENTAL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The investigators will compare 3 levels of PEEP (BASELINE versus PEEP INCREMENTAL versus PEEP DECREMENTAL). Baseline PEEP is based in the standard of care PEEP used in the participant units. PEEP decremental value is based in lung recruitment maneuver followed by a best compliance curve during PEEP decrements.
Intervention :PEEP DECREMENTAL</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP INCREMENTAL</intervention_name>
    <description>PEEP was progressively increased by steps of 2 cmH2O every 60 second until the end-expiratory transpulmonary pressure became positive between 0-2 cmH2O.</description>
    <arm_group_label>PEEP_Titration_INCREMENTAL</arm_group_label>
    <arm_group_label>PEEP_Titration_DECREMENTAL</arm_group_label>
    <other_name>PEEP_Titration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PEEP DECREMENTAL</intervention_name>
    <description>Lung recruitment maneuver (LRM) is a transitory and controlled increase in airway pressure to open collapsed alveoli. LRM is the first step of the PEEP DECREMENTAL method. After LRM, PEEP is systematically decreased, in small decrements, until the best respiratory system mechanics is identified.</description>
    <arm_group_label>PEEP_Titration_INCREMENTAL</arm_group_label>
    <arm_group_label>PEEP_Titration_DECREMENTAL</arm_group_label>
    <other_name>PEEP_Titration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICU admitted requiring intubation and mechanical ventilation

          -  BMI ≥ 35 kg/m2

          -  Waist circumference &gt; 88 cm (for women)

          -  Waist circumference &gt; 102 cm (for men)

        Exclusion Criteria:

          -  Known presence of esophageal varices

          -  Recent esophageal trauma or surgery

          -  Severe thrombocytopenia (Platelets count ≤ 5,000/mm3)

          -  Severe coagulopathy (INR ≥ 4)

          -  Presence or history of pneumothorax

          -  Pregnancy

          -  Patients with poor oxygenation index (PaO2/FiO2&lt; 100 mmHg with at least 10 cmH2O of
             PEEP)

          -  Pacemaker and/or internal cardiac defibrillator

          -  Hemodynamic parameters: systolic blood pressure (SBP) &lt;100 mmHg and &gt;180 mmHg, or if
             SBP is between 100-180 mmHg on high dose of IV continuous infusion norepinephrine (&gt;20
             μg per minute), or dobutamine (&gt;10 μg per minute), or dopamine (&gt;10 μg per Kg per
             minute), or epinephrine (&gt;10 μg per minute).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Kacmarek, RRT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lorenzo Berra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guérin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI. Review.</citation>
    <PMID>24467647</PMID>
  </reference>
  <reference>
    <citation>Behazin N, Jones SB, Cohen RI, Loring SH. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985). 2010 Jan;108(1):212-8. doi: 10.1152/japplphysiol.91356.2008. Epub 2009 Nov 12.</citation>
    <PMID>19910329</PMID>
  </reference>
  <reference>
    <citation>Borges JB, Suarez-Sipmann F, Bohm SH, Tusman G, Melo A, Maripuu E, Sandström M, Park M, Costa EL, Hedenstierna G, Amato M. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol (1985). 2012 Jan;112(1):225-36. doi: 10.1152/japplphysiol.01090.2010. Epub 2011 Sep 29.</citation>
    <PMID>21960654</PMID>
  </reference>
  <reference>
    <citation>Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, Hedenstierna G, Fredén F. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009 Nov;111(5):979-87. doi: 10.1097/ALN.0b013e3181b87edb.</citation>
    <PMID>19809292</PMID>
  </reference>
  <reference>
    <citation>Victorino JA, Borges JB, Okamoto VN, Matos GF, Tucci MR, Caramez MP, Tanaka H, Sipmann FS, Santos DC, Barbas CS, Carvalho CR, Amato MB. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med. 2004 Apr 1;169(7):791-800. Epub 2003 Dec 23.</citation>
    <PMID>14693669</PMID>
  </reference>
  <reference>
    <citation>Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009 Feb;15(1):18-24. Review.</citation>
    <PMID>19186406</PMID>
  </reference>
  <reference>
    <citation>Krishnan S, Schmidt GA. Acute right ventricular dysfunction: real-time management with echocardiography. Chest. 2015 Mar;147(3):835-846. doi: 10.1378/chest.14-1335. Review.</citation>
    <PMID>25732449</PMID>
  </reference>
  <reference>
    <citation>Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003 Feb;9(1):15-21. Review.</citation>
    <PMID>12548024</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Robert M. Kacmarek</investigator_full_name>
    <investigator_title>RRT, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
    <mesh_term>Pulmonary Atelectasis</mesh_term>
    <mesh_term>Dextrocardia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

